![Frontiers | The Role of Gut Microbiota-Bile Acids Axis in the Progression of Non-alcoholic Fatty Liver Disease Frontiers | The Role of Gut Microbiota-Bile Acids Axis in the Progression of Non-alcoholic Fatty Liver Disease](https://www.frontiersin.org/files/Articles/908011/fmicb-13-908011-HTML/image_m/fmicb-13-908011-g001.jpg)
Frontiers | The Role of Gut Microbiota-Bile Acids Axis in the Progression of Non-alcoholic Fatty Liver Disease
![Relative variations of gut microbiota in disordered cholesterol metabolism caused by high‐cholesterol diet and host genetics - Bo - 2017 - MicrobiologyOpen - Wiley Online Library Relative variations of gut microbiota in disordered cholesterol metabolism caused by high‐cholesterol diet and host genetics - Bo - 2017 - MicrobiologyOpen - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/822f6035-186b-47e1-934a-b3309c9b63d4/mbo3491-fig-0004-m.jpg)
Relative variations of gut microbiota in disordered cholesterol metabolism caused by high‐cholesterol diet and host genetics - Bo - 2017 - MicrobiologyOpen - Wiley Online Library
![Bile Acid Sequestrants for Hypercholesterolemia Treatment Using Sustainable Biopolymers: Recent Advances and Future Perspectives | Molecular Pharmaceutics Bile Acid Sequestrants for Hypercholesterolemia Treatment Using Sustainable Biopolymers: Recent Advances and Future Perspectives | Molecular Pharmaceutics](https://pubs.acs.org/cms/10.1021/acs.molpharmaceut.2c00007/asset/images/medium/mp2c00007_0017.gif)
Bile Acid Sequestrants for Hypercholesterolemia Treatment Using Sustainable Biopolymers: Recent Advances and Future Perspectives | Molecular Pharmaceutics
![2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task](https://www.jacc.org/cms/asset/0fbfe1c0-fd19-4747-9136-3e454df520a8/gr5.jpg)
2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task
![Cells | Free Full-Text | Why Bile Acids Are So Important in Non-Alcoholic Fatty Liver Disease (NAFLD) Progression Cells | Free Full-Text | Why Bile Acids Are So Important in Non-Alcoholic Fatty Liver Disease (NAFLD) Progression](https://www.mdpi.com/cells/cells-08-01358/article_deploy/html/images/cells-08-01358-g001.png)
Cells | Free Full-Text | Why Bile Acids Are So Important in Non-Alcoholic Fatty Liver Disease (NAFLD) Progression
![Nutrients | Free Full-Text | Polyphenol Effects on Cholesterol Metabolism via Bile Acid Biosynthesis, CYP7A1: A Review Nutrients | Free Full-Text | Polyphenol Effects on Cholesterol Metabolism via Bile Acid Biosynthesis, CYP7A1: A Review](https://pub.mdpi-res.com/nutrients/nutrients-11-02588/article_deploy/html/images/nutrients-11-02588-g001.png?1574985830)
Nutrients | Free Full-Text | Polyphenol Effects on Cholesterol Metabolism via Bile Acid Biosynthesis, CYP7A1: A Review
Taurine Alleviates Trimethylamine N-Oxide-Induced Atherosclerosis by Regulating Bile Acid Metabolism in ApoE–/– Mice | Journal of Agricultural and Food Chemistry
![2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Solution 2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Solution](https://www.jacc.org/cms/asset/fc511185-5e19-4d98-8444-30914b9ad0fe/gr7.jpg)
2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Solution
![Microorganisms | Free Full-Text | Bile Salt Hydrolases: At the Crossroads of Microbiota and Human Health Microorganisms | Free Full-Text | Bile Salt Hydrolases: At the Crossroads of Microbiota and Human Health](https://pub.mdpi-res.com/microorganisms/microorganisms-09-01122/article_deploy/html/images/microorganisms-09-01122-g001.png?1621674772)
Microorganisms | Free Full-Text | Bile Salt Hydrolases: At the Crossroads of Microbiota and Human Health
![Molecules | Free Full-Text | The Bioavailability and Biological Activities of Phytosterols as Modulators of Cholesterol Metabolism Molecules | Free Full-Text | The Bioavailability and Biological Activities of Phytosterols as Modulators of Cholesterol Metabolism](https://www.mdpi.com/molecules/molecules-27-00523/article_deploy/html/images/molecules-27-00523-g004.png)
Molecules | Free Full-Text | The Bioavailability and Biological Activities of Phytosterols as Modulators of Cholesterol Metabolism
![Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics | Signal Transduction and Targeted Therapy Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics | Signal Transduction and Targeted Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41392-022-01125-5/MediaObjects/41392_2022_1125_Fig1_HTML.png)
Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics | Signal Transduction and Targeted Therapy
![Gut microbiome-mediated mechanisms for reducing cholesterol levels: implications for ameliorating cardiovascular disease: Trends in Microbiology Gut microbiome-mediated mechanisms for reducing cholesterol levels: implications for ameliorating cardiovascular disease: Trends in Microbiology](https://www.cell.com/cms/attachment/6d925b1e-e466-49b5-a940-45d459a172cc/gr1_lrg.jpg)
Gut microbiome-mediated mechanisms for reducing cholesterol levels: implications for ameliorating cardiovascular disease: Trends in Microbiology
![2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Solution 2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Solution](https://www.jacc.org/cms/asset/783ee74c-9943-4508-bd5e-8be42baa2936/gr2c.jpg)
2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Solution
![Restructuring the Gut Microbiota by Intermittent Fasting Lowers Blood Pressure | Circulation Research Restructuring the Gut Microbiota by Intermittent Fasting Lowers Blood Pressure | Circulation Research](https://www.ahajournals.org/cms/asset/560d70a0-23cd-4d36-8507-802cb35fbc08/circresaha.120.318155.fig08.jpg)